CompuGroup Financial Statements From 2010 to 2024
0MSD Stock | 14.25 0.30 2.15% |
Gross Profit 411.7 M | Profit Margin 0.0212 | Market Capitalization 2 B | Revenue 1.2 B | Earnings Share 1.444 |
CompuGroup Medical Total Revenue |
|
Check CompuGroup Medical financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among CompuGroup Medical's main balance sheet or income statement drivers, such as Depreciation And Amortization of 121.6 M, Interest Expense of 25.5 M or Selling And Marketing Expenses of 10.9 M, as well as many indicators such as . CompuGroup financial statements analysis is a perfect complement when working with CompuGroup Medical Valuation or Volatility modules.
CompuGroup | Select Account or Indicator |
CompuGroup Medical Balance Sheet | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
CompuGroup Medical Income Statement | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
CompuGroup Medical Cash Flow Statement | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
CompuGroup Fundamental Market Drivers
Cash And Short Term Investments | 64.5 M |
About CompuGroup Medical Financial Statements
CompuGroup Medical shareholders use historical fundamental indicators, such as revenue or net income, to determine how well the company is positioned to perform in the future. Although CompuGroup Medical investors may analyze each financial statement separately, they are all interrelated. The changes in CompuGroup Medical's assets and liabilities, for example, are also reflected in the revenues and expenses on on CompuGroup Medical's income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.
Last Reported | Projected for Next Year | ||
Current Deferred Revenue | 220.1 M | 231.1 M | |
Total Revenue | 1.2 B | 622.4 M | |
Cost Of Revenue | 813.2 M | 853.8 M |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for CompuGroup Stock Analysis
When running CompuGroup Medical's price analysis, check to measure CompuGroup Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy CompuGroup Medical is operating at the current time. Most of CompuGroup Medical's value examination focuses on studying past and present price action to predict the probability of CompuGroup Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move CompuGroup Medical's price. Additionally, you may evaluate how the addition of CompuGroup Medical to your portfolios can decrease your overall portfolio volatility.